Product Overview & Details for Harvard Gastroenterology 2025
The Comprehensive 2025 Gastroenterology Update
Syllabus : Harvard CME _ Gastroenterology
Gastroenterology 2025
June 9 – 12, 2025
Overview
This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2025 program include:
- The newest guidelines for the use of biologics in IBD
- Therapeutic drug monitoring in IBD treatment
- Management of the older adult with IBD
- Updated guidelines for treatment of C. difficile infection
- Managing GI complications of immunotherapy and anti-neoplastic therapies
- Improved management of IBS
- Tips for managing fecal incontinence
- Management of refractory GERD
- Expanded genetic testing options to diagnose hereditary GI cancer syndromes
- Updated treatment of HBV and HCV
- Management of steatotic liver disease in 2025
- How to diagnose and manage cirrhosis
- How to improve your adenoma detection rate (ADR)
- Steps to ensure delivery of high-quality colonoscopic care
- Techniques to effectively control acute GI bleeding
- Endoscopic management of obesity
- When FMT is indicated for treatment
- New strategies to treat common GI problems
- A comprehensive update of national guidelines
As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover:
- IBD
- GI Complications of Immunotherapy
- Microscopic Colitis
- Steatotic Liver
- Barrett’s Esophagus
- Eosinophilic Esophagitis
- C. difficile Colitis
- Alcohol-Related Liver Disease
- Autoimmune Hepatitis
- IBS
- Refractory GERD
- Acute Pancreatitis
- Chronic Pancreatitis
- Celiac Disease
- GI Bleeding
- High Risk for Colorectal Cancer
Recent Advances and Innovations
Clinicians can rely on this program for education on:
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
- The stool microbiome: understanding the science behind clinical applications
- Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
- Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
- Endoscopic approaches to managing obesity
- Updated treatments for HBV and HCV
This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.
